Clinical Trial Update: Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dexmedetomidine for postoperative sedation after thoracoabdominal aortic aneurysm repair was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracoabdominal Aortic Aneurysm

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Sedation, Respiration, Artificial | Phase 4 | Status: TERMINATED | Results posted: 2009-09-16